MRNA - What's Going On With Moderna Stock Friday? | Benzinga
Moderna, Inc. (NASDAQ:MRNA) stock is trending on Friday. The company announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion for its RSV vaccine.
The Details: The RSV vaccine, mRNA-1345, is designed to protect adults aged 60 and older from respiratory disease caused by the RSV infection. As a result, the European Commission will authorize the vaccine.
The positive finding is based on data from the Phase 3 clinical trial ConquerRSV. The trial included 37,000 adults, aged ...